EIDD-3525 is a broad-spectrum antiviral against alphavirus infection that targets the nsP4 RNA-dependent RNA polymerase
Peiqi Yin, Shweta Choudhary, Sainan Wang, Bennett Davenport, Phong Truong, Zachary M. Sticher, Rebecca E. Krueger, Amalia Anne Cruz, McKenzie Smith, Alexander A. Kolykhalov, Dariia Vyshenska, Alexander L. Greninger, Shuli Mao, Michael G. Natchus, George R. Painter, , Thomas E. Morrison
This study identifies EIDD-3525 as a broad-spectrum antiviral against alphaviruses that inhibits RNA replication by targeting the nsP4 polymerase.
bioRxiv · Sep 28, 2026 · PreprintMicrobiology